The patent on the tuberculosis drug bedaquiline expires today. How an innovative deal will give millions access to cheaper TB drugs: ti.me/3NQ7DXO

TAG's annual Pipeline Reports are a key resource for communities, researchers, clinicians, & activists to keep up with R&D in HIV, TB, + HCV. Our reports on HIV cure, ART, PrEP, & vaccines, as well as long-acting formulations for HCV + more, are now live: treatmentactiongroup.org/resources/pipe…

Generic #bedaquiline coming soon for #Tuberculosis treatment. Stop TB Partnership GDF just posted a #bedaquiline tender stoptb.org/suppliers/proc… #EndTB

The Unitaid-funded BENEFIT Kids project is addressing critical gaps in research and helping the development of child-friendly formulations to improve the prevention and treatment of multidrug-resistant tuberculosis. Find out more: nature.com/articles/d4414…

#Pharma companies can commit to taking tangible action to developing and scaling responsible manufacturing practices that reduce their impact on AMR and the environment. Learn more through our recently published report below: #AMR #AntimicrobialResistance

📢BREAKING NEWS! Stop TB Partnership’s Global Drug Facility Announces Historic Price Reductions up to 55% for Bedaquiline, a Life-Saving Drug to Treat Drug-Resistant TB👉stoptb.org/news/stop-tbs-… #endTB

At October’s Research in Action Awards (RIAA), we’ll honor the Sentinel Project on Pediatric Drug-Resistant Tuberculosis for its tireless advocacy for kids with tough-to-treat TB; 3 of its accomplished founding members will be accepting the award. Info: treatmentactiongroup.org/support-us/ria…

Research by Unitaid, Johns Hopkins Medicine, and the The Aurum Institute shows that implementing a combined strategy of identifying household contacts and providing TB preventive treatment could save 850,000 lives by 2035: news.un.org/en/story/2023/… #EndTB

We're thrilled to announce 29 startups from across Africa joining the 2nd cohort of the Investing in Innovation (i3) program, a pan-African initiative for start-ups building the future of healthcare supply chains. 🌍💊 #innovation #healthcare #supplychain #africa

Three factors are needed for a sustainable antimicrobial market. 💊 Access 🏥 Stewardship 💡 Innovation Read Center for Global Development’s new report outlining six recommendations for policymakers to adopt ahead of the #UNGA High-Level Meeting on #AMR in 2024: bit.ly/46k05Eo

TAG + our 1/4/6x24 Campaign partners call on country governments to show global leadership + take action that goes beyond UN HLM political declaration to fully scale up access to shorter TB regimens + essential diagnostics by end of 2024. Our statement: treatmentactiongroup.org/statement/un-g…

👇 A new CGD publication with some clear action areas re AMR in LMICs. w Anthony McDonnell🇺🇦 Katherine Klemperer 🇺🇦 Morgan Pincombe @rsilv_dc Prashant Yadav (@prof-yadav.bsky.social) & Javier H Guzman Cruz #AMR #antibiotics #incentivealignment #externality #access #stewardship pubs.cgdev.org/amr/

The US is committed to ending TB by 2030 and today on the day of the #2023TBHLM, Dr. Atul Gawande, Assistant Administrator for USAID made some very big announcements to accelerate the fight again TB and reiterate USAID’s commitment to #endTB. #UNGA78 #UNGA

We applaud news from USAID + PEPFAR that they have secured a 30% price cut for TB Preventive Therapy (TPT) and are committing $25 million to provide 3HP to 2.5 million people  - a major step toward longtime TB community aims. Our statement: treatmentactiongroup.org/statement/tag-…

At last week’s UN High-Level Meeting on TB, TAG TB Project Officer David Branigan made the case that member states must make greater investments in TB R&D and commitments to access than stated in the political declaration. Watch it here: media.un.org/en/asset/k1j/k…

How to enable quality-assured supply, responsible distribution, and effective uptake and use of Reserve antibiotics, especially in LMICs? The #AMRConference has a special dedicated to it! Register here: bit.ly/3Ijwy4x

What’s next in the fight against TB? Join the session chaired by Stop TB Partnership partnership to stay up-to-date: Register here: bit.ly/3Ijwy4x

👉 Good news for the children with tuberculosis ! 👉 Buenas noticias para los niños con tuberculosis ! ➡️ erj.ersjournals.com/content/63/4/2… Antoni Noguera Hospital Sant Joan de Déu Barcelona ES SEIP SCPediatria PEDIATRIA CATALANA SCMIMC PII TB SEPAR @GEIM_SEIMC SEIMC Experimental TB Unit (UTE) of the IGTP-HUGTIP Hospital Sant Joan de Déu Barcelona CAT Salud Pública